Biotransformation and pharmacokinetics of prodrug 9-(β-d-1,3-dioxolan-4-yl)-2-aminopurine and its antiviral metabolite 9-(β-d-1,3-dioxolan-4-yl)guanine in mice
- 31 August 1997
- journal article
- Published by Elsevier in Antiviral Research
- Vol. 35 (3), 187-193
- https://doi.org/10.1016/s0166-3542(97)00028-4
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- High-performance liquid chromatographic determination of (−)-β-d-2-aminopurine dioxolane and (−)-β-d-2-amino-6-chloropurine dioxolane, and their metabolite (−)-β-d-dioxolane guanine in monkey serum, urine and cerebrospinal fluidJournal of Chromatography B: Biomedical Sciences and Applications, 1997
- Enhanced Brain Delivery of an Anti-HIV Nucleoside 2'-F-ara-ddI by Xanthine Oxidase Mediated BiotransformationJournal of Medicinal Chemistry, 1994
- L-.beta.-(2S,4S)- and L-.alpha.-(2S,4R)-dioxolanyl nucleosides as potential anti-HIV agents: asymmetric synthesis and structure-activity relationshipsJournal of Medicinal Chemistry, 1993
- 1,3-Dioxolanylpurine nucleosides (2R,4R) and (2R,4S) with selective anti-HIV-1 activity in human lymphocytesJournal of Medicinal Chemistry, 1993
- Prodrugs of the selective antiherpesvirus agent 9-[4-hydroxy-3-(hydroxymethyl)but-1-yl]guanine (BRL 39123) with improved gastrointestinal absorption propertiesJournal of Medicinal Chemistry, 1989
- 6-Deoxyacyclovir: a xanthine oxidase-activated prodrug of acyclovir.Proceedings of the National Academy of Sciences, 1984
- LAGRAN program for area and moments in pharmacokinetic analysisComputer Programs in Biomedicine, 1983